ORBIMED ADVISORS LLC: NBIX position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ORBIMED ADVISORS LLC on NBIX, newest first. How the timeline and the estimate are built.
ORBIMED ADVISORS LLC held 0 NBIX shares at 2026-03-31 per its 13F-HR filed 2026-05-15.
the latest 13F is the newest step
- period ended2026-03-3113F 0 sharesChange vs previous 13F -314,240 shares
13F-HR 0001172661-26-002369 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2025-12-3113F 314,240 sharesChange vs previous 13F -39,400 shares
0.91% of the 13F portfolio, value $44,568,659.
13F-HR 0001172661-26-001119 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 353,640 sharesChange vs previous 13F -84,900 shares
1.19% of the 13F portfolio, value $49,643,983.
13F-HR 0001172661-25-005047 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-06-3013F 438,540 sharesChange vs previous 13F -496,100 shares
1.39% of the 13F portfolio, value $55,120,093.
13F-HR 0001172661-25-003514 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 934,640 sharesChange vs previous 13F -3,480 shares
2.48% of the 13F portfolio, value $103,371,184.
13F-HR 0001172661-25-002355 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-12-3113F 938,120 sharesChange vs previous 13F +635,900 shares
2.66% of the 13F portfolio, value $128,053,380.
13F-HR 0001172661-25-001136 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 302,220 sharesChange vs previous 13F not available
0.64% of the 13F portfolio, value $34,821,788.
13F-HR 0001172661-24-005167 filed by ORBIMED ADVISORS LLC
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).